Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Moderna Inc | NASDAQ:MRNA | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.33 | -0.76% | 43.06 | 43.00 | 43.38 | 43.85 | 42.30 | 43.25 | 3,476,060 | 22:00:00 |
From Nov 2023 to Nov 2024
14:55 ET -- Moderna is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Shares were up 8% to $84.96 after Moderna and partner Merck disclosed positive trial results for an experimental mRNA-based treatment for skin cancer. On Wednesday, shares of Moderna and other makers of Covid-19 vaccines declined after Pfizer warned about slower demand for its Covid-19 products. Dow Jones & Co. owns Factiva. (josh.beckerman@wsj.com)
(END) Dow Jones Newswires
December 14, 2023 15:11 ET (20:11 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Moderna Chart |
1 Month Moderna Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
